1. European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
- Author
-
Renata Cifkova, Mike Rayner, Troels Thomsen, David R. Wood, Keith McGregor, Kalevi Pyörälä, Steven Humphries, Redford Williams, James Shepherd, Volkert Manger Cats, Annika Rosengren, Brian Oldenburg, Ali Oto, Ole Faergeman, Silvia G. Priori, Maciek Godycki-Cwirko, Jaap W. Deckers, Ian D. Graham, Carl-David Agardh, Neil Schneiderman, Jean Dallongeville, Maarten L. Simoons, Enrique Fernandez Burgos, Hans Christian Deter, Mario Sammut, Gianfranco Mazzotta, Guy De Backer, Giuseppe Mancia, Anthony Fitzgerald, Jean-Pierre Bassand, João Morais, John Lekakis, Otto A. Smiseth, Martin R. Cowie, Vedat Sansoy, Knut Borch-Johnsen, Pekka Puska, Carlos Brotons, Bertil Lindahl, Sigmund Silber, Robert J. Heine, Andrzej Budaj, Christian Albus, Susana Sans, Ettore Ambrosioni, Jean-Jacques Blanc, Alberto Zanchetti, Nuri Bages, Anthony M. Heagerty, Maria Angeles Alonso Garcia, Michal Tendera, Jose L. Rodicio, Joep Perk, Gunilla Burell, Ronan M. Conroy, Johannes Siegrist, Hans-Joachim Trappe, Philip Home, Silvia Priori, Udo Sechtem, Antti Uutela, Kristina Orth-Gomér, Shah Ebrahim, Christoph Hermann-Lingen, John Yarnell, and Veronica Dean
- Subjects
medicine.medical_specialty ,Medical education ,business.industry ,Process (engineering) ,media_common.quotation_subject ,Alternative medicine ,MEDLINE ,Guideline ,Task (project management) ,Clinical Practice ,medicine ,Quality (business) ,Cardiology and Cardiovascular Medicine ,Risk assessment ,business ,media_common - Abstract
Guidelines aim to present all the relevant evidence on a particular issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be helpful in everyday clinical decision-making. A great number of guidelines have been issued in recent years by different organizations-European Society of Cardiology (ESC), American Heart Association (AHA), American College of Cardiology (ACC), and other related societies. By means of links to web sites of National Societies several hundred guidelines are available. This profusion can put at stake the authority and validity of guidelines, which can only be guaranteed if they have been developed by an unquestionable decision-making process. This is one of the reasons why the ESC and others have issued recommendations for formulating and issuing guidelines. In spite of the fact that standards for issuing good quality guidelines are well defined, recent surveys of guidelines published in peer-reviewed journals between 1985 and 1998 have shown that methodological standards were not complied with in the vast majority of cases. It is therefore of great importance that guidelines and recommendations are presented in formats that are easily interpreted. Subsequently, their implementation programmes must also be well conducted. Attempts have been made to determine whether guidelines improve the quality of clinical practice and the utilization of health resources. In addition, the legal implications of medical guidelines have been discussed and examined, resulting in position documents, which have been published by a specific Task Force. The ESC Committee for Practice Guidelines (CPG) supervises and coordinates the preparation of new Guidelines and Expert Consensus Documents produced by Task Forces, expert groups or consensus panels. The Committee is also responsible for the endorsement of these guidelines or statements. The rationale for an active approach to the prevention of cardiovascular diseases (CVD) is …
- Published
- 2003